SPOTLIGHT -
Optimizing Therapy in Frontline Multiple Myeloma Not Eligible for Transplant
Experts in the multiple myeloma field discuss which front-line therapy is best for patients who are treatment ineligible.
Future Directions in Multiple Myeloma Care: Improvements and Unmet Needs
After reviewing implications of the MAIA study in multiple myeloma, experts consider unmet needs and future directions in care.
Patient Case #2: A 77-Year-Old Man With Newly Diagnosed MM
Panelists discuss the case of a 77-year-old man with newly diagnosed multiple myeloma who wishes to discontinue therapy after achieving a very good partial response.
Patient Case #1: A 75-Year-Old Woman With Newly Diagnosed MM
Experts review the case of a 75-year-old woman with newly diagnosed multiple myeloma and discuss treatment selection, continuation, reduction, and duration.
Treatment Options for First-Line Therapy in Transplant-Ineligible MM
In-depth considerations for available frontline therapy regimens for patients with transplant-ineligible multiple myeloma.
Transplant-Ineligible MM: Treatment After Adequate Response to Therapy
A panel of experts reflects on appropriate actions to take after a patient achieves adequate response to therapy for transplant-ineligible multiple myeloma.
Transplant-Ineligible Multiple Myeloma: Assessing Response to Therapy
Shared insight on how best to assess a patient’s response to therapy for transplant-ineligible multiple myeloma.
Multiple Myeloma: Transplant Ineligibility and Goals of Therapy
Panelists elucidate how to determine transplant ineligibility and the goals of therapy while managing a patient with multiple myeloma.
Challenges in Treating Transplant-Ineligible Multiple Myeloma
Shared insight on the difficulties of transplant-ineligible newly diagnosed multiple myeloma and how to optimally approach treatment.
